Contact

All Stories

  1. Suprachoroidal drug delivery: a versatile therapeutic platform

    Article • Expert Opinion on Drug Delivery, December 2024, Taylor & Francis

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  2. Three-Year Clinical Outcomes in Geographic Atrophy: An Analysis of 18,712 Patient Eyes

    Article • Retina, October 2024, Wolters Kluwer Health

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  3. Long-acting delivery and therapies for neovascular age-related macular degeneration

    Article • Expert Opinion on Biological Therapy, July 2024, Taylor & Francis

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  4. Safety and Tolerability of Suprachoroidal Axitinib, CLS-AX, for Neovascular AMD; Phase 1/2a Open-Label, Dose-Escalation Trial

    Article • Ophthalmology Science, July 2024, Elsevier

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  5. Gene Therapy for Non-Hereditary Retinal Disease: Age-Related Macular Degeneration, Diabetic Retinopathy, and Beyond

    Article • Genes, June 2024, MDPI AG

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  6. Safety and Efficacy of CLS-TA by Anatomic Location of Inflammation: Results from the Phase 3 PEACHTREE Clinical Trial

    Article • Ocular Immunology and Inflammation, January 2024, Taylor & Francis

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  7. Effect of Race and Insurance Status on Treatment and Outcomes in Diabetic Retinopathy: Analysis of 43 274 Eyes Using the IRIS Registry

    Article • Journal of VitreoRetinal Diseases, January 2024, SAGE Publications

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  8. The complement system: a novel therapeutic target for Age-related macular degeneration

    Article • Expert Opinion on Pharmacotherapy, September 2023, Taylor & Francis

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  9. The evolving therapeutic landscape of diabetic retinopathy

    Article • Expert Opinion on Biological Therapy, August 2023, Taylor & Francis

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  10. Optical coherence tomography outcomes as biomarkers for disease status, visual function, and prognosis in diabetic macular edema

    Article • Canadian Journal of Ophthalmology, February 2023, Elsevier

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  11. Aging Effects on Optic Nerve Neurodegeneration

    Article • International Journal of Molecular Sciences, January 2023, MDPI AG

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  12. Triamcinolone Acetonide Suprachoroidal Injectable Suspension for Uveitic Macular Edema: Integrated Analysis of Two Phase 3 Studies

    Article • Ophthalmology and Therapy, November 2022, Springer Science + Business Media

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  13. Advancements in ocular gene therapy delivery: vectors and subretinal, intravitreal, and suprachoroidal techniques

    Article • Expert Opinion on Biological Therapy, September 2022, Taylor & Francis

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  14. Progress in the pharmacotherapy of uveitis: the art of personalized care

    Article • Expert Opinion on Pharmacotherapy, July 2022, Taylor & Francis

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  15. Longer-Term Anti-VEGF Therapy Outcomes in Neovascular Age-Related Macular Degeneration, Diabetic Macular Edema, and Vein Occlusion-Related Macular Edema

    Article • Ophthalmology Retina, April 2022, Elsevier

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  16. A randomized, double-masked, multicenter trial of topical acrizanib (LHA510), a tyrosine kinase VEGF-receptor inhibitor, in treatment-experienced subjects with neovascular age-related macular degeneration

    Article • American Journal of Ophthalmology, March 2022, Elsevier

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  17. Sustained release glaucoma therapies: Novel modalities for overcoming key treatment barriers associated with topical medications

    Article • Annals of Medicine, January 2022, Taylor & Francis

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  18. Disease Progression Pathways of Wet AMD: Opportunities for New Target Discovery

    Article • Expert Opinion on Therapeutic Targets, January 2022, Taylor & Francis

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  19. Suprachoroidal CLS‐TA versus Rescue Therapies for the Treatment of Uveitic Macular Edema: A Post Hoc Analysis of PEACHTREE

    Article • Clinical and Experimental Ophthalmology, November 2021, Wiley

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  20. OCT Anatomic and Temporal Biomarkers in Uveitic Macular Edema

    Article • American Journal of Ophthalmology, November 2021, Elsevier

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  21. Suprachoroidal CLS-TA with and without Systemic Corticosteroid and/or Steroid-Sparing Therapy: A Post-Hoc Analysis of the Phase 3 PEACHTREE Clinical Trial

    Article • Ocular Immunology and Inflammation, August 2021, Taylor & Francis

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  22. Genetics of Diabetic Retinopathy, a Leading Cause of Irreversible Blindness in the Industrialized World

    Article • Genes, July 2021, MDPI AG

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  23. Glaucoma Heritability: Molecular Mechanisms of Disease

    Article • Genes, July 2021, MDPI AG

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  24. Physics-based modeling of Age-related Macular Degeneration—A theoretical approach to quantify retinal and choroidal contributions to macular oxygenation

    Article • Mathematical Biosciences, June 2021, Elsevier

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  25. Understanding the genetic pathology of Stargardt disease: a review of current findings and challenges

    Article • Expert Opinion on Orphan Drugs, March 2021, Taylor & Francis

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  26. Suprachoroidal Delivery of Small Molecules, Nanoparticles, Gene and Cell Therapies for Ocular Diseases

    Article • Pharmaceutics, February 2021, MDPI AG

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  27. Suprachoroidal CLS-TA for non-infectious uveitis: an open-label, safety trial (AZALEA)

    Article • British Journal of Ophthalmology, February 2021, BMJ

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  28. Biomechanics of suprachoroidal drug delivery: From benchtop to clinical investigation in ocular therapies

    Article • Expert Opinion on Drug Delivery, January 2021, Taylor & Francis

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  29. Molecular Genetics of Glaucoma: Subtype and Ethnicity Considerations

    Article • Genes, December 2020, MDPI AG

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  30. RNA Therapeutics for Retinal Diseases

    Article • Expert Opinion on Biological Therapy, December 2020, Taylor & Francis

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  31. Visual acuity outcomes and anti-VEGF therapy intensity in macular oedema due to retinal vein occlusion: a real-world analysis of 15 613 patient eyes

    Article • British Journal of Ophthalmology, October 2020, BMJ

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  32. Microbial Spectrum and Antibacterial Susceptibility of Endophthalmitis Cultures in a Tertiary Referral Center in the Midwestern United States: An Analysis From 295 Patients

    Article • Journal of VitreoRetinal Diseases, September 2020, SAGE Publications

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  33. Anti-Integrin therapy for retinovascular diseases

    Article • Expert Opinion on Investigational Drugs, July 2020, Taylor & Francis

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  34. Evolution of Primary Scleral Buckling Surgery: A Modified Lean Six Sigma Technique to Improve Surgical Efficiency

    Article • Ophthalmic Surgery Lasers and Imaging Retina, May 2020, SLACK, Inc.

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  35. Visual acuity outcomes and anti-VEGF therapy intensity in diabetic macular oedema: a real-world analysis of 28 658 patient eyes

    Article • British Journal of Ophthalmology, April 2020, BMJ

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  36. Suprachoroidal Delivery of Viral and Nonviral Gene Therapy for Retinal Diseases

    Article • Journal of Ocular Pharmacology and Therapeutics, April 2020, Mary Ann Liebert Inc

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  37. Retinal oximetry in glaucoma: investigations and findings reviewed

    Article • Acta Ophthalmologica, April 2020, Wiley

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  38. Voretigene neparvovec-rzyl for treatment of RPE65-mediated inherited retinal diseases: a model for ocular gene therapy development

    Article • Expert Opinion on Biological Therapy, March 2020, Taylor & Francis

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  39. Investigational plasma kallikrein inhibitors for the treatment of diabetic macular edema: an expert assessment

    Article • Expert Opinion on Investigational Drugs, January 2020, Taylor & Francis

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  40. Visual Acuity Outcomes and Anti–Vascular Endothelial Growth Factor Therapy Intensity in Neovascular Age-Related Macular Degeneration Patients

    Article • Ophthalmology Retina, January 2020, Elsevier

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  41. Efficacy and Safety of Suprachoroidal CLS-TA for Macular Edema Secondary to Noninfectious Uveitis

    Article • Ophthalmology, January 2020, Elsevier

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  42. Current and upcoming anti-VEGF therapies and dosing strategies for the treatment of neovascular AMD: a comparative review

    Article • BMJ Open Ophthalmology, December 2019, BMJ

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  43. Cost-effectiveness of Voretigene Neparvovec-rzyl vs Standard Care for RPE65-Mediated Inherited Retinal Disease

    Article • JAMA Ophthalmology, October 2019, American Medical Association (AMA)

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  44. Tie-2/Angiopoietin pathway modulation as a therapeutic strategy for retinal disease

    Article • Expert Opinion on Investigational Drugs, September 2019, Taylor & Francis

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  45. Important Considerations in Modeling the Cost-Effectiveness for the First Food and Drug Administration–Approved Gene Therapy and Implications for Future One-Time Therapies

    Article • Value in Health, August 2019, Elsevier

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  46. Efficacy and safety of bromfenac 0.075% formulated in DuraSite for pain and inflammation in cataract surgery

    Article • Expert Opinion on Pharmacotherapy, July 2019, Taylor & Francis

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  47. Innovative therapies for neovascular age-related macular degeneration

    Article • Expert Opinion on Pharmacotherapy, July 2019, Taylor & Francis

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  48. Vascular dysfunction in retinitis pigmentosa

    Article • Acta Ophthalmologica, May 2019, Wiley

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  49. Complement inhibition as a therapeutic strategy in retinal disorders

    Article • Expert Opinion on Biological Therapy, January 2019, Taylor & Francis

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  50. Estimation of impact of RPE65-mediated inherited retinal disease on quality of life and the potential benefits of gene therapy

    Article • British Journal of Ophthalmology, January 2019, BMJ

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  51. Pathological Consequences of Vascular Alterations in the Eye

    Article • January 2019, Springer Science + Business Media

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  52. Vitreous Pathology

    Article • January 2019, Springer Science + Business Media

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  53. Vitreous Physiology

    Article • January 2019, Springer Science + Business Media

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  54. Real-world Outcomes of Anti–Vascular Endothelial Growth Factor Therapy in Diabetic Macular Edema in the United States

    Article • Ophthalmology Retina, December 2018, Elsevier

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  55. Vital Dyes in Vitreomacular Surgery

    Article • Ophthalmic Surgery Lasers and Imaging Retina, October 2018, SLACK, Inc.

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  56. Stargardt macular dystrophy and evolving therapies

    Article • Expert Opinion on Biological Therapy, September 2018, Taylor & Francis

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla, Harry Flynn

  57. Real-world Outcomes of Anti–Vascular Endothelial Growth Factor Therapy in Neovascular Age-Related Macular Degeneration in the United States

    Article • Ophthalmology Retina, July 2018, Elsevier

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  58. The acute and chronic effects of intravitreal anti-vascular endothelial growth factor injections on intraocular pressure: A review

    Article • Survey of Ophthalmology, May 2018, Elsevier

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  59. Comparison of Monthly vs Treat-and-Extend Regimens for Individuals With Macular Edema Who Respond Well to Anti–Vascular Endothelial Growth Factor Medications

    Article • JAMA Ophthalmology, April 2018, American Medical Association (AMA)

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla, Jennifer Lim

  60. Pharmacotherapy of retinal disease with visual cycle modulators

    Article • Expert Opinion on Pharmacotherapy, March 2018, Taylor & Francis

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  61. Gene therapy for inherited retinal and optic nerve degenerations

    Article • Expert Opinion on Biological Therapy, October 2017, Taylor & Francis

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla, Nuria Morral

  62. Treatment Burden in Neovascular AMD:Visual Acuity Outcomes are Associated With Anti-VEGF Injection Frequency

    Article • Ophthalmic Surgery Lasers and Imaging Retina, October 2017, SLACK, Inc.

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  63. Gene therapy for age-related macular degeneration

    Article • Expert Opinion on Biological Therapy, July 2017, Taylor & Francis

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  64. Emerging vascular endothelial growth factor antagonists to treat neovascular age-related macular degeneration

    Article • Expert Opinion on Emerging Drugs, July 2017, Taylor & Francis

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  65. LEAN SIX SIGMA TECHNIQUES TO IMPROVE OPHTHALMOLOGY CLINIC EFFICIENCY

    Article • Retina, July 2017, Wolters Kluwer Health

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  66. Induced pluripotent stem cell-based therapy for age-related macular degeneration

    Article • Expert Opinion on Biological Therapy, June 2017, Taylor & Francis

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  67. Dual Antagonism of PDGF and VEGF in Neovascular Age-Related Macular Degeneration

    Article • Ophthalmology, February 2017, Elsevier

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  68. EFFICACY OF DEXAMETHASONE INTRAVITREAL IMPLANT FOR REFRACTORY MACULAR EDEMA CAUSED BY RETINAL VEIN OCCLUSION

    Article • Retinal Cases & Brief Reports, December 2016, Wolters Kluwer Health

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  69. RANIBIZUMAB FOR DIABETIC MACULAR EDEMA REFRACTORY TO MULTIPLE PRIOR TREATMENTS

    Article • Retina, July 2016, Wolters Kluwer Health

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  70. Angiographic Cystoid Macular Edema and Outcomes in the Comparison of Age-Related Macular Degeneration Treatments Trials

    Article • Ophthalmology, April 2016, Elsevier

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  71. Outcomes in Eyes with Retinal Angiomatous Proliferation in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT)

    Article • Ophthalmology, March 2016, Elsevier

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  72. Treatment strategies for refractory diabetic macular edema: switching anti-VEGF treatments, adopting corticosteroid-based treatments, and combination therapy

    Article • Expert Opinion on Biological Therapy, January 2016, Informa Healthcare

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  73. Incidence, Risk Factors, and Timing of Elevated Intraocular Pressure After Intravitreal Triamcinolone Acetonide Injection for Macular Edema Secondary to Retinal Vein Occlusion

    Article • JAMA Ophthalmology, September 2015, American Medical Association (AMA)

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  74. Subretinal Hyperreflective Material in the Comparison of Age-Related Macular Degeneration Treatments Trials

    Article • Ophthalmology, September 2015, Elsevier

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  75. Influence of the Vitreomacular Interface on Treatment Outcomes in the Comparison of Age-Related Macular Degeneration Treatments Trials

    Article • Ophthalmology, June 2015, Elsevier

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  76. Outcomes of Eyes with Lesions Composed of >50% Blood in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT)

    Article • Ophthalmology, February 2015, Elsevier

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  77. Efficacy of Intravitreal Ocriplasmin for Treatment of Vitreomacular Adhesion

    Article • Ophthalmology, January 2015, Elsevier

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  78. Sustained Delivery Fluocinolone Acetonide Vitreous Implants

    Article • Ophthalmology, October 2014, Elsevier

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  79. Comparison of Optical Coherence Tomography Assessments in the Comparison of Age-Related Macular Degeneration Treatments Trials

    Article • Ophthalmology, October 2014, Elsevier

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  80. The Prevalence and Incidence of Epiretinal Membranes in Eyes With Inactive Extramacular CMV Retinitis

    Article • Investigative Ophthalmology & Visual Science, July 2014, Association for Research in Vision and Ophthalmology (ARVO)

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  81. Sporadic Visual Acuity Loss in the Comparison of Age-Related Macular Degeneration Treatments Trials (CATT)

    Article • American Journal of Ophthalmology, July 2014, Elsevier

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  82. VEGFAandVEGFR2Gene Polymorphisms and Response to Anti–Vascular Endothelial Growth Factor Therapy

    Article • JAMA Ophthalmology, May 2014, American Medical Association (AMA)

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  83. Treatment of diabetic macular edema with sustained-release glucocorticoids: intravitreal triamcinolone acetonide, dexamethasone implant, and fluocinolone acetonide implant

    Article • Expert Opinion on Pharmacotherapy, March 2014, Informa Healthcare

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  84. Factors affecting visual outcomes in patients with diabetic macular edema treated with ranibizumab

    Article • Eye, November 2013, Springer Science + Business Media

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  85. Pazopanib eye drops: a randomised trial in neovascular age-related macular degeneration

    Article • British Journal of Ophthalmology, November 2013, BMJ

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  86. Dexamethasone Intravitreal Implant in Combination with Laser Photocoagulation for the Treatment of Diffuse Diabetic Macular Edema

    Article • Ophthalmology, September 2013, Elsevier

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  87. Macular Morphology and Visual Acuity in the Comparison of Age-related Macular Degeneration Treatments Trials

    Article • Ophthalmology, September 2013, Elsevier

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  88. Exploratory Analysis of the Effect of Intravitreal Ranibizumab or Triamcinolone on Worsening of Diabetic Retinopathy in a Randomized Clinical Trial

    Article • JAMA Ophthalmology, August 2013, American Medical Association (AMA)

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  89. Comparison of Treatment Regimens for Cytomegalovirus Retinitis in Patients with AIDS in the Era of Highly Active Antiretroviral Therapy

    Article • Ophthalmology, June 2013, Elsevier

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  90. Twelve-Month Efficacy and Safety of 0.5 mg or 2.0 mg Ranibizumab in Patients with Subfoveal Neovascular Age-related Macular Degeneration

    Article • Ophthalmology, May 2013, Elsevier

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  91. Aqueous Levels of Fluocinolone Acetonide after Administration of Fluocinolone Acetonide Inserts or Fluocinolone Acetonide Implants

    Article • Ophthalmology, March 2013, Elsevier

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  92. Ranibizumab for Edema of the Macula in Diabetes Study

    Article • JAMA Ophthalmology, February 2013, American Medical Association (AMA)

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  93. Non-cytomegalovirus Ocular Opportunistic Infections in Patients With Acquired Immunodeficiency Syndrome

    Article • American Journal of Ophthalmology, February 2013, Elsevier

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  94. Ranibizumab Versus Photodynamic Therapy for Presumed Ocular Histoplasmosis Syndrome

    Article • Ophthalmic Surgery Lasers and Imaging Retina, January 2013, SLACK, Inc.

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  95. Baseline Predictors for One-Year Visual Outcomes with Ranibizumab or Bevacizumab for Neovascular Age-related Macular Degeneration

    Article • Ophthalmology, January 2013, Elsevier

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  96. Enzymatic Vitreolysis with Ocriplasmin for Vitreomacular Traction and Macular Holes

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, August 2012, New England Journal of Medicine (NEJM/MMS)

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  97. Ranibizumab and Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration

    Article • Ophthalmology, July 2012, Elsevier

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  98. Incidence of Cytomegalovirus Retinitis in the Era of Highly Active Antiretroviral Therapy

    Article • American Journal of Ophthalmology, June 2012, Elsevier

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  99. Impaired ocular blood flow regulation in patients with open-angle glaucoma and diabetes

    Article • Clinical and Experimental Ophthalmology, May 2012, Wiley

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  100. Evaluation of the United States Public Health Service Guidelines for Discontinuation of Anticytomegalovirus Therapy After Immune Recovery in Patients With Cytomegalovirus Retinitis

    Article • American Journal of Ophthalmology, October 2011, Elsevier

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  101. Changes in Vision- and Health-Related Quality of Life in Patients with Diabetic Macular Edema Treated with Pegaptanib Sodium or Sham

    Article • Investigative Ophthalmology & Visual Science, September 2011, Association for Research in Vision and Ophthalmology (ARVO)

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  102. Primary Endpoint Results of a Phase II Study of Vascular Endothelial Growth Factor Trap-Eye in Wet Age-related Macular Degeneration

    Article • Ophthalmology, June 2011, Elsevier

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  103. A Phase 2/3, Multicenter, Randomized, Double-Masked, 2-Year Trial of Pegaptanib Sodium for the Treatment of Diabetic Macular Edema

    Article • Ophthalmology, June 2011, Elsevier

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  104. Association of Host Genetic Risk Factors With the Course of Cytomegalovirus Retinitis in Patients Infected With Human Immunodeficiency Virus

    Article • American Journal of Ophthalmology, June 2011, Elsevier

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  105. Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, May 2011, New England Journal of Medicine (NEJM/MMS)

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  106. Patient preferences in the treatment of diabetic retinopathy

    Article • Patient Preference and Adherence, May 2011, Taylor & Francis

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  107. Long-term Benefit of Sustained-Delivery Fluocinolone Acetonide Vitreous Inserts for Diabetic Macular Edema

    Article • Ophthalmology, April 2011, Elsevier

    Dr Amod Gupta, Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  108. Ranibizumab for Choroidal Neovascularization Secondary to Causes Other Than Age-Related Macular Degeneration: A Phase I Clinical Trial

    Article • Ophthalmology, January 2011, Elsevier

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  109. Two-Year Outcomes of the Ranibizumab for Edema of the mAcula in Diabetes (READ-2) Study

    Article • Ophthalmology, November 2010, Elsevier

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla, Jennifer Lim

  110. Excess Mortality in Patients with AIDS in the Era of Highly Active Antiretroviral Therapy: Temporal Changes and Risk Factors

    Article • Clinical Infectious Diseases, October 2010, Oxford University Press (OUP)

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  111. Sustained Ocular Delivery of Fluocinolone Acetonide by an Intravitreal Insert

    Article • Ophthalmology, July 2010, Elsevier

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  112. Response to: Combined treatment of intravitreal bevacizumab and intravitreal triamcinolone in patients with retinal vein occlusion by Schroff et al.,

    Article • Graefe s Archive for Clinical and Experimental Ophthalmology, March 2010, Springer Science + Business Media

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  113. Diabetic macular oedema: physical, physiological and molecular factors contribute to this pathological process

    Article • Acta Ophthalmologica, March 2010, Wiley

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  114. Combined treatment of intravitreal bevacizumab and intravitreal triamcinolone in patients with retinal vein occlusion: 6 months of follow-up

    Article • Graefe s Archive for Clinical and Experimental Ophthalmology, November 2009, Springer Science + Business Media

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  115. INTRAVITREAL BEVACIZUMAB FOR CHOROIDAL NEOVASCULARIZATION SECONDARY TO PRESUMED OCULAR HISTOPLASMOSIS SYNDROME

    Article • Retina, November 2009, Wolters Kluwer Health

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  116. Anti-vascular endothelial growth factor therapy for neovascular ocular diseases other than age-related macular degeneration

    Article • Current Opinion in Ophthalmology, May 2009, Wolters Kluwer Health

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  117. Antivascular endothelial growth factor therapy for neovascular age-related macular degeneration

    Article • Current Opinion in Ophthalmology, May 2009, Wolters Kluwer Health

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  118. Age-related macular degeneration and the aging eye

    Article • Clinical Interventions in Aging, September 2008, Taylor & Francis

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  119. Therapeutic effects of ranibizumab in neovascular age-related macular degeneration

    Article • Expert Review of Ophthalmology, October 2007, Taylor & Francis

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  120. How the diabetic eye loses vision

    Article • Endocrine, September 2007, Springer Science + Business Media

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  121. The Relationship Between Retrobulbar and Choroidal Hemodynamics in Non-Neovascular Age-Related Macular Degeneration

    Article • Ophthalmic Surgery Lasers and Imaging Retina, May 2007, SLACK, Inc.

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  122. Squalamine lactate for the treatment of age-related macular degeneration

    Article • Expert Review of Ophthalmology, April 2007, Taylor & Francis

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  123. Ranibizumab

    Article • Drugs, January 2007, Springer Science + Business Media

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  124. SUSTAINED RESPONSE TO MULTIPLE INTRAVITREAL TRIAMCINOLONE ACETONIDE INJECTIONS IN A PATIENT WITH PREDOMINANTLY OCCULT CHOROIDAL NEOVASCULARIZATION

    Article • Retinal Cases & Brief Reports, January 2007, Wolters Kluwer Health

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  125. Ranibizumab Combined With Verteporfin Photodynamic Therapy in Neovascular Age-Related Macular Degeneration

    Article • Archives of Ophthalmology, November 2006, American Medical Association (AMA)

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  126. Ranibizumab for Treatment of Neovascular Age-Related Macular Degeneration

    Article • Ophthalmology, April 2006, Elsevier

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  127. Retinal and Choroidal Blood Flow in Health and Disease

    Article • January 2006, Elsevier

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  128. ORAL ADMINISTRATION OF LUMIRACOXIB REDUCES CHOROIDAL NEOVASCULAR MEMBRANE DEVELOPMENT IN THE RAT LASER-TRAUMA MODEL

    Article • Retina, December 2005, Wolters Kluwer Health

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  129. HUMAN VITREOUS DISTRIBUTION OF LINEZOLID AFTER A SINGLE ORAL DOSE

    Article • Retina, July 2005, Wolters Kluwer Health

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  130. Anastomotic Vessels Remain Viable after Photodynamic Therapy in Primate Models of Choroidal Neovascularization

    Article • Investigative Ophthalmology & Visual Science, June 2005, Association for Research in Vision and Ophthalmology (ARVO)

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  131. Erratum

    Article • Current Opinion in Ophthalmology, June 2005, Wolters Kluwer Health

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  132. New and classic insights into presumed ocular histoplasmosis syndrome and its treatment

    Article • Current Opinion in Ophthalmology, June 2005, Wolters Kluwer Health

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  133. Current and future pharmacological intervention for diabetic retinopathy

    Article • Expert Opinion on Emerging Drugs, May 2005, Informa Healthcare

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  134. Future pharmacological treatment options for nonexudative and exudative age-related macular degeneration

    Article • Expert Opinion on Emerging Drugs, February 2005, Informa Healthcare

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  135. MV-6401, a potent photosensitizer: a review of the current state of photosensitizing agents for the treatment of exudative age-related macular degeneration

    Article • Drugs of the Future, January 2005, Prous Science

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  136. Photodynamic therapy with PhotoPoint photosensitiser MV6401, indium chloride methyl pyropheophorbide, achieves selective closure of rat corneal neovascularisation and rabbit choriocapillaris

    Article • British Journal of Ophthalmology, January 2005, BMJ

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  137. Pharmacotherapy for diabetic retinopathy

    Article • Current Opinion in Ophthalmology, December 2004, Wolters Kluwer Health

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  138. Macular pigment density and aging, assessed in the normal elderly and those with cataracts and age-related macular degeneration

    Article • American Journal of Ophthalmology, October 2004, Elsevier

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  139. EVALUATION OF PHOTOPOINT PHOTOSENSITIZER MV6401, INDIUM CHLORIDE METHYL PYROPHEOPHORBIDE, AS A PHOTODYNAMIC THERAPY AGENT IN PRIMATE CHORIOCAPILLARIS AND LASER-INDUCED CHOROIDAL NEOVASCULARIZATION

    Article • Retina, August 2004, Wolters Kluwer Health

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  140. Corticosteroids in posterior segment disease: an update on new delivery systems and new indications

    Article • Current Opinion in Ophthalmology, June 2004, Wolters Kluwer Health

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  141. Laser trabecular sclerosis for chronic hypotony after vitreoretinal surgery

    Article • Ophthalmology, February 2004, Elsevier

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  142. The Squirrel Monkey: Characterization of a New-World Primate Model of Experimental Choroidal Neovascularization and Comparison with the Macaque

    Article • Investigative Ophthalmology & Visual Science, February 2004, Association for Research in Vision and Ophthalmology (ARVO)

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  143. Diagnostic Imaging of Retinal Disease

    Article • International Ophthalmology Clinics, January 2004, Wolters Kluwer Health

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  144. Current and Future Treatment Options for Nonexudative and Exudative Age-Related Macular Degeneration

    Article • Drugs & Aging, January 2004, Springer Science + Business Media

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  145. Squalamine Lactate Reduces Choroidal Neovascularization in a Laser-Injury Model in the Rat

    Article • Retina, December 2003, Wolters Kluwer Health

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  146. Diabetic Retinopathy and Diabetic Macular Edema: Pathophysiology, screening, and novel therapies

    Article • Diabetes Care, August 2003, American Diabetes Association

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  147. Bacterial endophthalmitis prophylaxis

    Article • Ophthalmology, August 2003, Elsevier

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  148. Choroidal neovascular membrane inhibition in a laser treated rat model with intraocular sustained release triamcinolone acetonide microimplants

    Article • British Journal of Ophthalmology, August 2003, BMJ

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  149. The effects of dorzolamide on choroidal and retinal perfusion in non-exudative age related macular degeneration

    Article • British Journal of Ophthalmology, June 2003, BMJ

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  150. Leber congenital amaurosis associated with optic disk neovascularization and vitreous hemorrhage

    Article • American Journal of Ophthalmology, May 2003, Elsevier

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  151. Recent advances in the treatment of exudative age-related macular degeneration, including transpupillary thermotherapy

    Article • Acta Ophthalmologica Scandinavica, April 2003, Wiley

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  152. Proton therapy for exudative age-related macular degeneration: a randomized, sham-controlled clinical trial

    Article • American Journal of Ophthalmology, December 2002, Elsevier

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  153. Ocular perfusion abnormalities in diabetes

    Article • Acta Ophthalmologica Scandinavica, October 2002, Wiley

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  154. Novel approaches for retinal drug delivery

    Article • Ophthalmology Clinics of North America, September 2002, Elsevier

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  155. An update on photodynamic therapy in age-related macular degeneration

    Article • Expert Opinion on Pharmacotherapy, July 2002, Informa Healthcare

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  156. DIAGNOSTIC AND THERAPEUTIC CHALLENGES

    Article • Retina, June 2002, Wolters Kluwer Health

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  157. Intravitreal triamcinolone in subfoveal recurrence of choroidal neovascularisation after laser treatment in macular degeneration

    Article • British Journal of Ophthalmology, May 2002, BMJ

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  158. Choroidal perfusion perturbations in non-neovascular age related macular degeneration

    Article • British Journal of Ophthalmology, February 2002, BMJ

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  159. LOCALIZATION OF ROSE BENGAL, ALUMINUM PHTHALOCYANINE TETRASULFONATE, AND CHLORIN e6 IN THE RABBIT EYE

    Article • Retina, February 2002, Wolters Kluwer Health

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  160. Bacterial endophthalmitis prophylaxis for cataract surgery

    Article • Ophthalmology, January 2002, Elsevier

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  161. Presumed ocular histoplasmosis syndrome: update on epidemiology, pathogenesis, and photodynamic, antiangiogenic, and surgical therapies

    Article • Current Opinion in Ophthalmology, December 2001, Wolters Kluwer Health

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  162. Relation between dietary intake, serum concentrations, and retinal concentrations of lutein and zeaxanthin in adults in a Midwest population

    Article • American Journal of Clinical Nutrition, December 2001, Oxford University Press (OUP)

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  163. Delayed suprachoroidal hemorrhage after glaucoma filtration procedures1 1The authors have no financial or proprietary interest in any aspect of this study.

    Article • Ophthalmology, October 2001, Elsevier

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  164. Evolving pathophysiological paradigms for age related macular degeneration

    Article • British Journal of Ophthalmology, May 2001, BMJ

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  165. Macular pigment optical density in a midwestern sample

    Article • Ophthalmology, April 2001, Elsevier

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  166. Ocular perfusion and age-related macular degeneration

    Article • Acta Ophthalmologica Scandinavica, April 2001, Wiley

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  167. Intravitreal Triamcinolone Acetonide Inhibits Choroidal Neovascularization in a Laser-Treated Rat Model

    Article • Archives of Ophthalmology, March 2001, American Medical Association (AMA)

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  168. Anti-angiogenic therapy of proliferative diabetic retinopathy

    Article • Expert Opinion on Pharmacotherapy, March 2001, Informa Healthcare

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  169. Potential therapeutic application of antisense oligonucleotides in the treatment of ocular diseases

    Article • Expert Opinion on Pharmacotherapy, February 2001, Informa Healthcare

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  170. Changing therapeutic paradigms in CMV retinitis in AIDS

    Article • Expert Opinion on Pharmacotherapy, December 2000, Informa Healthcare

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  171. Aging Affects the Retrobulbar Circulation Differently in Women and Men

    Article • Archives of Ophthalmology, August 2000, American Medical Association (AMA)

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  172. Endothelin-1-Mediated Retinal Artery Vasospasm and the Rabbit Electroretinogram

    Article • Journal of Ocular Pharmacology and Therapeutics, August 2000, Mary Ann Liebert Inc

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  173. MACULAR BUCKLING FOR RETINAL DETACHMENT DUE TO MACULAR HOLE IN HIGHLY MYOPIC EYES WITH POSTERIOR STAPHYLOMA

    Article • Retina, May 2000, Wolters Kluwer Health

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  174. Vasoprotection as neuroprotection for the optic nerve

    Article • Eye, May 2000, Springer Science + Business Media

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  175. INTRAVITREAL TRIAMCINOLONE ACETONIDE IN EXUDATIVE AGE-RELATED MACULAR DEGENERATION

    Article • Retina, March 2000, Wolters Kluwer Health

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  176. Olestra Consumption Is Not Associated with Macular Pigment Optical Density in a Cross-Sectional Volunteer Sample in Indianapolis

    Article • Journal of Nutrition, March 2000, Oxford University Press (OUP)

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  177. Update on acute and chronic endophthalmitis

    Article • Ophthalmology, December 1999, Elsevier

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  178. Changing therapeutic paradigms for exudative age-related macular degeneration: antiangiogenic agents and photodynamic therapy

    Article • Expert Opinion on Investigational Drugs, December 1999, Informa Healthcare

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  179. Corticosteroids as an Antiangiogenic Agent for Histoplasmosis-Related Subfoveal Choroidal Neovascularization

    Article • Journal of Ocular Pharmacology and Therapeutics, October 1999, Mary Ann Liebert Inc

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  180. Color Doppler imaging discloses reduced ocular blood flow velocities in nonexudative age-related macular degeneration

    Article • American Journal of Ophthalmology, July 1999, Elsevier

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  181. Mitochondrial maculopathy: geographic atrophy of the macula in the MELAS associated A to G 3243 mitochondrial DNA point mutation

    Article • American Journal of Ophthalmology, July 1999, Elsevier

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  182. Ginkgo biloba Extract Increases Ocular Blood Flow Velocity

    Article • Journal of Ocular Pharmacology and Therapeutics, June 1999, Mary Ann Liebert Inc

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  183. Progress in measurement of ocular blood flow and relevance to our understanding of glaucoma and age-related macular degeneration

    Article • Progress in Retinal and Eye Research, April 1999, Elsevier

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  184. Comparison of intraocular to plasma HIV-1 viral burden in patients with cytomegalovirus retinitis

    Article • American Journal of Ophthalmology, February 1999, Elsevier

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  185. Regulation of Retinal and Optic Nerve Blood Flow

    Article • Archives of Ophthalmology, November 1998, American Medical Association (AMA)

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  186. Age-Related Macular Degeneration

    Article • Survey of Ophthalmology, September 1998, Elsevier

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  187. THE USE OF DYE DILUTION CURVE ANALYSIS IN THE QUANTIFICATION OF INDOCYANINE GREEN ANGIOGRAMS OF THE HUMAN CHOROID

    Article • Ophthalmology Clinics of North America, September 1998, Elsevier

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  188. Correspondence

    Article • American Journal of Ophthalmology, July 1998, Elsevier

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  189. Repair of retinal detachments due to Herpes varicella-zoster virus retinitis

    Article • Ophthalmology, March 1998, Elsevier

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  190. Evolution of a full-thickness macular hole

    Article • American Journal of Ophthalmology, February 1998, Elsevier

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  191. Radiation Therapy For Exudative Age-Related Macular Degeneration

    Article • Retina, January 1998, Wolters Kluwer Health

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  192. Talc Embolism: A Static Retinopathy

    Article • American Journal of Ophthalmology, December 1997, Elsevier

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  193. Vascular Endothelial Growth Factor-Induced Retinal Permeability Is Mediated by Protein Kinase C In Vivo and Suppressed by an Orally Effective  -Isoform-Selective Inhibitor

    Article • Diabetes, September 1997, American Diabetes Association

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  194. EXOGENOUS ASPERGILLUS NIGER ENDOPHTHALMITIS IN A PATIENT WITH A FILTERING BLEB

    Article • Retina, September 1997, Wolters Kluwer Health

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  195. Surgical Treatment of a Macular Hole Secondary to Accidental Laser Burn

    Article • Archives of Ophthalmology, July 1997, American Medical Association (AMA)

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  196. Blebitis, Early EndophthalmitS, and Late Endophthalmitis after Glaucoma-filtering Surgery

    Article • Ophthalmology, June 1997, Elsevier

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  197. Uveal lymphoid neoplasia: A clinical-pathologic correlation and review of the early form

    Article • Survey of Ophthalmology, May 1997, Elsevier

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  198. Subretinal Aspiration Biopsy of Ocular Lymphoma

    Article • American Journal of Ophthalmology, March 1997, Elsevier

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  199. Acute Progressive Multifocal Best's Disease in a 61 -year-old Man

    Article • American Journal of Ophthalmology, January 1997, Elsevier

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  200. Postvitrectomy Positioning Complicated by Ulnar Nerve Palsy

    Article • American Journal of Ophthalmology, November 1996, Elsevier

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  201. Ocular Antimicrobial Therapy

    Article • January 1996, Taylor & Francis

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  202. Endophthalmitis Following Glaucoma Filtering Surgery

    Article • International Ophthalmology Clinics, January 1996, Wolters Kluwer Health

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  203. INTRAVITREAL TOXICITY OF DENTAL ADHESIVES IN THE RABBIT

    Article • Retina, January 1996, Wolters Kluwer Health

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  204. Serpiginous Choroiditis

    Article • International Ophthalmology Clinics, January 1996, Wolters Kluwer Health

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  205. SEVERE PENETRATING EYE TRAUMA CAUSED BY FISH PICK ACCIDENTS

    Article • Retina, January 1996, Wolters Kluwer Health

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  206. Herpes Simplex Virus Corneal Dendrite

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, December 1995, New England Journal of Medicine (NEJM/MMS)

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  207. Vitreous amyloidosis in familial amyloidotic polyneuropathy. Report of a case with the Val30Met transthyretin mutation

    Article • Survey of Ophthalmology, November 1995, Elsevier

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  208. Laser photodisruption of visible retinal artery emboli.

    Article • British Journal of Ophthalmology, October 1995, BMJ

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  209. Retinal artery occlusion in rabbit eyes using human atheroma

    Article • Current Eye Research, January 1995, Taylor & Francis

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  210. Seronegative myasthenia gravis: A plasma factor inhibiting agonist-induced acetylcholine receptor function copurifies with IgM

    Article • Annals of Neurology, October 1991, Wiley

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  211. A susceptibility locus for multiple sclerosis is linked to the T cell receptor β chain complex

    Article • Cell, June 1989, Elsevier

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  212. PHOTOSENSITIZATION OF SINGLE-STRAND BREAKS IN pBR322 DNA BY ROSE BENGAL

    Article • Photochemistry and Photobiology, March 1989, Wiley

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  213. A simple method for DNA purification from peripheral blood

    Article • Analytical Biochemistry, November 1988, Elsevier

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  214. Molecular Genotypes of the T-Cell Receptor Beta Chain in Families with Multiple Sclerosis

    Article • Annals of the New York Academy of Sciences, November 1988, Wiley

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla

  215. PHOTOADDITION OF CHLORPROMAZINE TO GUANOSINE-5'-MONOPHOSPHATE

    Article • Photochemistry and Photobiology, June 1986, Wiley

    Volunteer Clinical Professor, Indiana University School of Medicine Thomas Ciulla